NCT01650519 - A Pilot Study to Determine the Efficacy of Intravenous Ibuprofen for Pain Control Following Arthroscopic Knee Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

January 31, 2013

Conditions

Arthroscopic Knee Surgery

Interventions

DRUG

IV ibuprofen

800 mg intravenous ibuprofen administered intravenously over 10 minutes.

DRUG

IV ketorolac

30 mg ketorolac for patients \< 65 years of age (15 mg ketorolac for patients \> 65 years of age) administered intravenously over no less than 15 seconds

Trial Locations (1)

43210

The Ohio State University, Wexner Medical Center, Columbus